clofibrate and niacin

clofibrate has been researched along with niacin in 71 studies

Research

Studies (71)

Timeframe	Studies, this research(%)	All Research%
pre-1990	41 (57.75)	18.7374
1990's	18 (25.35)	18.2507
2000's	2 (2.82)	29.6817
2010's	10 (14.08)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baggaley, KH; Fears, R; Hindley, RM; Morgan, B; Murrell, E; Thorne, DE	1
Kump, W; Mueller, K; Tosch, W; Traxler, P	1
Bagge, P; Dron, DI; Fenton, G; Jones, GD; Newton, CG; Riddell, D; Wyman, BM	1
Ashford, A; Ashton, MJ; Loveless, AH; Riddell, D; Salmon, J; Stevenson, GV	1
Cayen, MN; Jirkovsky, I	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Campillo, NE; Guerra, A; Páez, JA	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Bai, Z; He, D; Li, J; Liu, B; Wang, Y; Wang, Z; Zhang, J; Zhang, Q; Zhao, Q	1
Steiner, G	1
Capurso, A	1
Hunninghake, DB	2
Borhani, NO	1
Costa, C; Guarini, G; Santese, D; Trimarco, C; Vitaliano, E	1
Ojeda, G; Portolés, A; Portolés, MP; Rojo, JM	1
Romics, L	1
Ritter, KS	1
Kane, JP; Malloy, MJ	1
Naito, HK	1
Hirai, Y; Kawakami, M; Koyama, S; Mishima, Y; Mizutani, A; Morishita, S; Saito, T	1
Davignon, J	1
Blum, CB; Levy, RI	1
Nikkilä, EA; Tikkanen, MJ	1
Perry, RS	1
Havel, RJ; Kane, JP	2
Malinow, MR	1
Gotto, AM; Jones, PH; Scott, LW	1
Packard, CJ; Shepherd, J	1
Stuyt, PM	1
Berge, KG; Canner, PL; Friedewald, W; Friedman, L; Prineas, RJ; Stamler, J; Wenger, NK	1
Cayen, MN	1
Gibson, P; Lloyd, J; West, R	1
Altmayer, P; Garrett, ER	1
Parker, F	1
Chasseaud, LF; Schatton, W; Taylor, T; Waller, AR	1
Stamler, J	1
De Boer, HH; Hendriks, T; Van Niekerk, JL	1
Oehme, FW; Onyeama, HP	1
Barthel, U; Haller, H; Hanefeld, M; Hora, C; Rothe, G; Schulze, J	1
Gorelova, NR; Nikulina, GG; Petrun, NM; Pyrig, LA	1
Gustafsson, K; Kiessling, H	2
Steger, W	1
Gotto, AM; Yeshurun, D	1
Bays, H; Lansing, AM	1
Franceschini, G; Paoletti, R	1
Auwerx, J; Fruchart, JC; Staels, B; Van Tol, A	1
Fujita, Y; Kimura, A; Mori, Y; Sano, K; Shin, M; Umezawa, C; Yoshida, K	1
Holme, I	1
Bambauer, R; Müller, UA; Schiel, R	1
Kondo, T; Marugami, M; Shibata, K; Umezawa, C	1
Farmer, JA; Gotto, AM	1
Hashimoto, C; Nakakita, S; Sano, K; Shin, M; Umezawa, C	1
Knopp, RH	1
Sano, K; Shin, M; Umezawa, C	1
de Boer, A; Fishman, PA; Heckbert, SR; Klungel, OH; Leufkens, HG; Psaty, BM; Sullivan, SD; Veenstra, DL	1
BEST, MM; DUNCAN, CH; ROBERTSON, GL	1
Bertolami, MC	1
Knight, M; Sando, KR	1

Reviews

22 review(s) available for clofibrate and niacin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Effects of various lipid-lowering treatments in diabetics. Journal of cardiovascular pharmacology, 1990, Volume: 16 Suppl 9 Topics: Clofibrate; Diabetes Complications; Diabetes Mellitus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipoproteins; Niacin	1990
Drugs affecting triglycerides. Cardiology, 1991, Volume: 78, Issue:3 Topics: Benzhydryl Compounds; Clofibrate; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Niacin	1991
Drug treatment of dyslipoproteinemia. Endocrinology and metabolism clinics of North America, 1990, Volume: 19, Issue:2 Topics: Bile Acids and Salts; Clofibrate; Coronary Disease; Drug Therapy, Combination; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipoproteinemias; Niacin; Probucol	1990
[Basic principles of drug therapy of hyperlipoproteinemia]. Orvosi hetilap, 1988, Nov-06, Volume: 129, Issue:45 Topics: Adult; Anticholesteremic Agents; Cholesterol; Clofibrate; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Ion Exchange Resins; Lipoproteins, HDL; Lipoproteins, LDL; Niacin	1988
When to treat hyperlipidemia. Advances in internal medicine, 1988, Volume: 33 Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Neomycin; Niacin; Pentanoic Acids; Risk Factors; Triglycerides	1988
Reducing cardiac deaths with hypolipidemic drugs. Postgraduate medicine, 1987, Nov-01, Volume: 82, Issue:6 Topics: Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Feeding Behavior; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins, LDL; Niacin; Patient Education as Topic; Pentanoic Acids; Probucol	1987
Contemporary recommendations for evaluating and treating hyperlipidemia. Clinical pharmacy, 1986, Volume: 5, Issue:2 Topics: Clofibrate; Dextrothyroxine; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Phenotype; Probucol	1986
Treatment of hypercholesterolemia. Annual review of medicine, 1986, Volume: 37 Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats	1986
The diagnosis and management of hyperlipidemia. Disease-a-month : DM, 1986, Volume: 32, Issue:5 Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides	1986
Pharmacological modification of lipoprotein metabolism. Biochemical Society transactions, 1987, Volume: 15, Issue:2 Topics: Animals; Bile Acids and Salts; Cholestyramine Resin; Clofibrate; Colestipol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Intestinal Absorption; Lipoproteins; Niacin; Sterols	1987
Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man. Pharmacology & therapeutics, 1985, Volume: 29, Issue:2 Topics: Animals; Binding Sites; Biological Availability; Biotransformation; Clofibrate; Drug Interactions; Humans; Hypolipidemic Agents; Intestinal Absorption; Kidney Diseases; Kinetics; Liver Diseases; Mixed Function Oxygenases; Niacin; Protein Binding; Species Specificity; Tissue Distribution	1985
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriosclerosis. Circulation, 1984, Volume: 69, Issue:5 Topics: Cholesterol; Clofibrate; Coronary Disease; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Lactation; Lipoproteins; Lovastatin; Naphthalenes; Niacin; Pentanoic Acids; Pregnancy; Pregnancy Complications; Probucol; Tangier Disease; Triglycerides	1984
The treatment of familial hypercholesterolaemia by partial ileal bypass surgery. A review of the literature. The Netherlands journal of medicine, 1984, Volume: 27, Issue:1 Topics: Anticholesteremic Agents; Cholesterol; Clofibrate; Diarrhea; Heterozygote; Homozygote; Humans; Hyperlipoproteinemia Type II; Ileum; Lovastatin; Methods; Naphthalenes; Niacin; Postoperative Complications	1984
A literature review of paraquat toxicity. Veterinary and human toxicology, 1984, Volume: 26, Issue:6 Topics: Acetylcysteine; Animals; Butylated Hydroxytoluene; Clofibrate; Collagen; Diquat; Drug Synergism; Humans; Niacin; Oxygen; Paraquat; Pulmonary Fibrosis; Rats; Superoxide Dismutase; Vitamin E	1984
Therapy of hyperlipidemic states. Annual review of medicine, 1982, Volume: 33 Topics: Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Colestipol; Dietary Fats; Drug Therapy, Combination; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipoproteins, LDL; Lipoproteins, VLDL; Niacin; Nicotinic Acids; Sitosterols	1982
Hyperlipidemia: perspectives in diagnosis and treatment. Southern medical journal, 1995, Volume: 88, Issue:4 Topics: Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Fat-Restricted; Diet, Reducing; Exercise; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Niacin; Probucol; Risk; Triglycerides	1995
Pharmacological control of hypertriglyceridemia. Cardiovascular drugs and therapy, 1993, Volume: 7, Issue:3 Topics: Body Weight; Cardiovascular Diseases; Clofibrate; Exercise; Fatty Acids, Omega-3; Humans; Hypertriglyceridemia; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Niacin; Risk Factors	1993
Relationship between total mortality and cholesterol reduction as found by meta-regression analysis of randomized cholesterol-lowering trials. Controlled clinical trials, 1996, Volume: 17, Issue:1 Topics: Anticholesteremic Agents; Cholesterol; Clofibrate; Coronary Disease; Humans; Myocardial Infarction; Niacin; Placebos; Randomized Controlled Trials as Topic; Regression Analysis	1996
Choosing the right lipid-regulating agent. A guide to selection. Drugs, 1996, Volume: 52, Issue:5 Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Niacin; Triglycerides	1996
Drug treatment of lipid disorders. The New England journal of medicine, 1999, Aug-12, Volume: 341, Issue:7 Topics: Anion Exchange Resins; Cardiovascular Diseases; Clofibrate; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Male; Niacin; Risk Factors	1999
Nonstatin therapies for management of dyslipidemia: a review. Clinical therapeutics, 2015, Oct-01, Volume: 37, Issue:10 Topics: Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Cholesterol, LDL; Clofibrate; Disease Management; Dyslipidemias; Ezetimibe; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Niacin; Proprotein Convertases; Risk Factors; Saccharomyces cerevisiae Proteins; Triglycerides; United States	2015

Trials

5 trial(s) available for clofibrate and niacin

Article	Year
[Effects on lipid metabolism of inhibitors of cholesterol synthesis]. La Clinica terapeutica, 1988, Apr-15, Volume: 125, Issue:1 Topics: Aged; Anticholesteremic Agents; Cholesterol; Clinical Trials as Topic; Clofibrate; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipid Metabolism; Lipids; Lovastatin; Male; Middle Aged; Niacin; Triglycerides	1988
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. Journal of the American College of Cardiology, 1986, Volume: 8, Issue:6 Topics: Adult; Aspirin; Clofibrate; Dextrothyroxine; Estrogens; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Niacin; Time Factors	1986
Pharmacological trials: primary and secondary prevention of coronary heart disease. Preventive medicine, 1983, Volume: 12, Issue:1 Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone	1983
[Therapy of lipoproteinemia. Comparison between Lipo-Merz retard and a commercial combination drug]. Fortschritte der Medizin, 1980, May-15, Volume: 98, Issue:18 Topics: Adult; Aged; Cholesterol; Clofibrate; Clofibric Acid; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Female; Humans; Hyperlipoproteinemias; Male; Middle Aged; Niacin; Nicotinic Acids; Triglycerides	1980
Four years' treatment efficacy of patients with severe hyperlipidemia. Lipid lowering drugs versus LDL-apheresis. The International journal of artificial organs, 1995, Volume: 18, Issue:12 Topics: Adolescent; Adult; Anticholesteremic Agents; Blood Component Removal; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Enzyme-Linked Immunosorbent Assay; Female; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Longitudinal Studies; Lovastatin; Male; Middle Aged; Niacin; Pravastatin; Quality of Life	1995

Other Studies

44 other study(ies) available for clofibrate and niacin

Article	Year
Hypolipidemic analogues of ethyl 4-benzyloxybenzoate. Journal of medicinal chemistry, 1977, Volume: 20, Issue:11 Topics: Animals; Benzoates; Body Weight; Cholesterol; Fatty Acids; Hypolipidemic Agents; Liver; Male; Organ Size; Rats; Structure-Activity Relationship; Triglycerides	1977
Hypolipidemic activity of rifamycin derivatives. Journal of medicinal chemistry, 1990, Volume: 33, Issue:2 Topics: Animals; Chemical Phenomena; Chemistry; DNA-Directed RNA Polymerases; Hypolipidemic Agents; Rats; Rats, Inbred Strains; Rifamycins; Staphylococcal Infections; Structure-Activity Relationship	1990
Hypolipidemic 2-[4-(1,1-dimethylethyl)phenyl]-4H-3,1-benzoxazin-4-ones. Structure-activity relationships of a novel series of high-density lipoprotein elevators. Journal of medicinal chemistry, 1989, Volume: 32, Issue:1 Topics: Animals; Chemical Phenomena; Chemistry; Cholesterol; Cholesterol, HDL; Hypercholesterolemia; Hypolipidemic Agents; Male; Oxazines; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Triglycerides	1989
Heterocyclic analogues of chlorcyclizine with potent hypolipidemic activity. Journal of medicinal chemistry, 1984, Volume: 27, Issue:10 Topics: Animals; Body Weight; Chemical Phenomena; Chemistry; Cholesterol, Dietary; Eating; Hypolipidemic Agents; Indicators and Reagents; Male; Piperazine; Rats; Rats, Inbred Strains; Structure-Activity Relationship	1984
Hypolipidemic 4,5-dihydro-4-oxo-5,5-disubstituted-2-furancarboxylic acids. Journal of medicinal chemistry, 1982, Volume: 25, Issue:10 Topics: Animals; Chemical Phenomena; Chemistry; Clofibrate; Furans; Hypolipidemic Agents; Liver; Male; Niacin; Organ Size; Rats; Rats, Inbred Strains; Triglycerides	1982
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Neural computational prediction of oral drug absorption based on CODES 2D descriptors. European journal of medicinal chemistry, 2010, Volume: 45, Issue:3 Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Anti-atherosclerosis effect of H Bioorganic & medicinal chemistry, 2019, 08-01, Volume: 27, Issue:15 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Atherosclerosis; Cell Line; Cell Proliferation; Cell Survival; Clofibrate; Dose-Response Relationship, Drug; Human Umbilical Vein Endothelial Cells; Humans; Hydrogen Sulfide; Mice; Molecular Structure; Niacin; RAW 264.7 Cells; Structure-Activity Relationship	2019
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1991, Jan-11, Volume: 33, Issue:835 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Lovastatin; Neomycin; Niacin; Probucol	1991
Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases. Cardiology, 1985, Volume: 72, Issue:5-6 Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clofibrate; Coronary Disease; Dextrothyroxine; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Estrogens; Humans; Hypertension; Myocardial Infarction; Niacin; Sulfinpyrazone	1985
Immunomodulatory activity of anti-atherogenic drugs: effects on blastogenesis, humoral response, delayed hypersensitivity and passive anaphylaxis by immune complexes. Immunopharmacology, 1985, Volume: 9, Issue:2 Topics: Anaphylaxis; Animals; Antibody Formation; Antigen-Antibody Complex; Arteriosclerosis; Clofibrate; Clofibric Acid; Cyclic AMP; Cyclic GMP; Female; Hypersensitivity, Delayed; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Niacin; Thiophenes; Ticlopidine	1985
Steinernema feltiae (= Neoaplectana carpocapsae): effect of sterols and hypolipidemic agents on development. Experimental parasitology, 1988, Volume: 67, Issue:2 Topics: Animals; Anticholesteremic Agents; Caseins; Cholesterol; Cholestyramine Resin; Clofibrate; Culture Media; Dextrothyroxine; Female; Globulins; Hemin; Hydrogen-Ion Concentration; Male; Moths; Myoglobin; Nematoda; Niacin; Sterols	1988
[Strains and species differences in experimental hyperlipidemia]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1986, Volume: 87, Issue:3 Topics: Animals; Clofibrate; Disease Models, Animal; Gemfibrozil; Glycerides; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Niacin; Pentanoic Acids; Pyridines; Rats; Rats, Inbred Strains; Species Specificity	1986
Medical management of hyperlipidemia and the role of probucol. The American journal of cardiology, 1986, Jun-27, Volume: 57, Issue:16 Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Female; Gemfibrozil; Humans; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Middle Aged; Niacin; Pentanoic Acids; Phenols; Probucol; Risk	1986
Rational drug therapy of the hyperlipoproteinemias, Part II. Rational drug therapy, 1986, Volume: 20, Issue:10 Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol	1986
Current pharmacologic treatment of elevated serum cholesterol. Circulation, 1987, Volume: 76, Issue:3 Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides	1987
Adverse effects of the treatment for hyperlipidemia. Cardiology clinics, 1986, Volume: 4, Issue:1 Topics: Anion Exchange Resins; Anticholesteremic Agents; Bibliographies as Topic; Clofibrate; Diet; Drug Therapy, Combination; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Physical Exertion; Probucol; Risk	1986
[Drugs in hyperlipidemia]. Nederlands tijdschrift voor geneeskunde, 1987, Sep-05, Volume: 131, Issue:36 Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypolipidemic Agents; Neomycin; Niacin	1987
Addition to labeling of cholestyramine. FDA drug bulletin, 1985, Volume: 15, Issue:1 Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Drug Labeling; Gemfibrozil; Humans; Hypolipidemic Agents; Niacin; Pentanoic Acids; Probucol; Thyroxine; United States; United States Food and Drug Administration	1985
Lipid-lowering drugs. The Medical letter on drugs and therapeutics, 1985, Aug-30, Volume: 27, Issue:695 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides	1985
Treatment of homozygous familial hypercholesterolaemia: an informative sibship. British medical journal (Clinical research ed.), 1985, Oct-19, Volume: 291, Issue:6502 Topics: Adolescent; Age Factors; Arteriosclerosis; Cholestyramine Resin; Clofibrate; Female; Homozygote; Humans; Hyperlipoproteinemia Type II; Infant; Male; Middle Aged; Niacin	1985
Disposition of etofibrate, clofibric and nicotinic acid esters, and their products in dogs. Journal of pharmaceutical sciences, 1985, Volume: 74, Issue:3 Topics: Animals; Clofibrate; Clofibric Acid; Dogs; Esters; Half-Life; Hypolipidemic Agents; Injections, Intravenous; Kinetics; Male; Niacin; Solubility; Solvents; Time Factors	1985
Xanthomas and hyperlipidemias. Journal of the American Academy of Dermatology, 1985, Volume: 13, Issue:1 Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis	1985
Bioavailability studies of etofibrate in rhesus monkeys. Arzneimittel-Forschung, 1985, Volume: 35, Issue:2 Topics: Animals; Biological Availability; Clofibrate; Clofibric Acid; Drug Interactions; Female; Half-Life; Hypolipidemic Agents; Intestinal Absorption; Macaca mulatta; Niacin; Time Factors	1985
Reduced incidence of cardiovascular complications and mortality in hyperlipoproteinemia (HLP) with effective lipid correction. The Dresden HLP study. Atherosclerosis, 1984, Volume: 53, Issue:1 Topics: Adolescent; Adult; Cerebrovascular Disorders; Cholesterol; Cholestyramine Resin; Clofibrate; Combined Modality Therapy; Dietary Fats; Drug Therapy, Combination; Germany, East; Humans; Hyperlipoproteinemias; Middle Aged; Myocardial Infarction; Niacin; Physical Exertion; Triglycerides	1984
Abnormalities of lipid metabolism and methods of their correction in patients with glomerulonephritis. International urology and nephrology, 1984, Volume: 16, Issue:4 Topics: Adolescent; Adult; Arteriosclerosis; Clofibrate; Dipyridamole; Female; Glomerulonephritis; Humans; Hyperlipidemias; Lipids; Male; Middle Aged; Niacin	1984
Pharmacologic therapy for the hyperlipidemic patient. The American journal of medicine, 1983, May-23, Volume: 74, Issue:5A Topics: Bile Acids and Salts; Clofibrate; Dextrothyroxine; Humans; Hyperlipidemias; Hypolipidemic Agents; Niacin; Probucol	1983
The spontaneously hyperlipidemic old rat as a model for evaluation of hypolipoproteinemic drugs. Effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins. Zeitschrift fur Versuchstierkunde, 1982, Volume: 24, Issue:5-6 Topics: Aging; Animals; Cholesterol; Clofibrate; Drug Evaluation, Preclinical; Hyperlipidemias; Lipoproteins; Male; Niacin; Propionates; Rats; Rats, Inbred Strains; Triglycerides	1982
The mouse as a model for evaluation of hypotriglyceridemic drugs effects of nicotinic acid, clofibrate and ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate on plasma lipoproteins. Zeitschrift fur Versuchstierkunde, 1982, Volume: 24, Issue:5-6 Topics: Animals; Cholesterol; Clofibrate; Drug Evaluation, Preclinical; Lipoproteins; Male; Mice; Mice, Inbred Strains; Niacin; Triglycerides	1982
Fish oil (omega-3 fatty acids) in treatment of hypertriglyceridemia. A practical approach for the primary care physician. The Journal of the Kentucky Medical Association, 1994, Volume: 92, Issue:3 Topics: Aged; Clofibrate; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Gemfibrozil; Humans; Hypertriglyceridemia; Lipids; Lovastatin; Niacin; Primary Health Care	1994
Choice of cholesterol-lowering drugs. The Medical letter on drugs and therapeutics, 1993, Mar-05, Volume: 35, Issue:891 Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol	1993
Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat. Israel journal of medical sciences, 1996, Volume: 32, Issue:6 Topics: Actins; Animals; Apolipoproteins; Cholestyramine Resin; Clofibrate; Fenofibrate; Gene Expression Regulation; Hypolipidemic Agents; Intestinal Mucosa; Lipid Metabolism; Lipoproteins, HDL; Liver; Lovastatin; Male; Niacin; Probucol; Rats; Rats, Wistar; Simvastatin	1996
NAD+ biosynthesis and metabolic fluxes of tryptophan in hepatocytes isolated from rats fed a clofibrate-containing diet. Biochemical pharmacology, 1996, Jul-26, Volume: 52, Issue:2 Topics: Animals; Cells, Cultured; Clofibrate; Diet; Liver; Male; NAD; Niacin; Pentosyltransferases; Rats; Rats, Sprague-Dawley; Tryptophan	1996
Increased conversion ratio of tryptophan to niacin by the administration of clofibrate, a hypolipidemic drug, to rats. Bioscience, biotechnology, and biochemistry, 1996, Volume: 60, Issue:9 Topics: Animals; Clofibrate; Hypolipidemic Agents; Liver; Male; NAD; Niacin; Niacinamide; Rats; Rats, Wistar; Tryptophan; Weaning; Weight Gain	1996
NAD+ biosynthesis from tryptophan in the presence of nicotinic acid or vice versa by rat hepatocytes--effect of clofibrate-feeding. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, 1998, Volume: 68, Issue:2 Topics: Animals; Biological Transport; Clofibrate; Glutarates; Hydrolases; Liver; Male; Microbodies; NAD; Niacin; Rats; Rats, Sprague-Dawley; Tryptophan	1998
Effects of peroxisome-proliferators on the TRP-NAD pathway. Advances in experimental medicine and biology, 1999, Volume: 467 Topics: Animals; Carboxy-Lyases; Cells, Cultured; Clofibrate; Female; Liver; Male; NAD; NADP; Niacin; Oxidation-Reduction; Pentosyltransferases; Peroxisome Proliferators; Peroxisomes; Phenothiazines; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Transcription Factors; Tryptophan	1999
Lipid-lowering drug use and cardiovascular events after myocardial infarction. The Annals of pharmacotherapy, 2002, Volume: 36, Issue:5 Topics: Cholesterol; Clofibrate; Cohort Studies; Coronary Artery Disease; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Niacin; Pravastatin; Risk Factors; Simvastatin; Stroke; Treatment Outcome	2002
A COMPARISON OF THE EFFECTS OF ETHYL CHLOROPHENOXYISOBUTYRATE AND NICOTINIC ACID ON PLASMA FREE FATTY ACIDS. Lancet (London, England), 1965, Jan-23, Volume: 1, Issue:7378 Topics: Anticholesteremic Agents; Butyrates; Clofibrate; Fatty Acids; Fatty Acids, Nonesterified; Glycerides; Lipid Metabolism; Lipids; Niacin; Niacinamide; Nicotinic Acids; Norepinephrine; Pharmacology; Statistics as Topic	1965
[Mechanisms of hepatotoxicity]. Arquivos brasileiros de cardiologia, 2005, Volume: 85 Suppl 5 Topics: Chemical and Drug Induced Liver Injury; Clofibrate; Drug Interactions; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver Diseases; Niacin	2005